News

Hosted on MSN1mon
ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up
The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and dual GIP/GIP-1 receptor agonists for type 2 diabetes or obesity and ...
News Medical1mon
GLP-1 agonists may reshape the gut microbiome
The American Diabetes Association (ADA) now recommends GLP-1 agonists for overweight individuals with diabetes, particularly those who experience frequent hypoglycemia with insulin or sulfonylureas.
Hosted on MSN10mon
New weight loss drugs are on the way — and the health benefits are even more promising
Pharmaceutical companies are racing to develop new weight loss drugs following the success of Ozempic and Wegovy — and this latest round of medications could come with more health benefits and ...
Medscape23d
Topline Results Positive for Lilly’s Oral GLP-1 Orforglipron
Orforglipron, Eli Lilly’s investigational oral glucagon-like peptide 1 receptor agonist (GLP-1 RA), achieved positive ... American Diabetes Association (ADA) 85th Scientific Sessions and will ...